The number of COVID-19 shots supplied in the U.S. is expected to hit 240 million by next week. According to White House, Pfizer , Moderna , and Johnson & Johnson all on pace to achieve quarterly production guides.
240 million doses would be adequate to fully vaccinate 130 million people.
J&J is expected to deliver at least 11 million doses next week – that puts it on target to hit 20 million doses by the end of March.
“We’ve done a lot to help J&J; we’re monitoring that very closely and we anticipate a significant increase at the end of this month, which will enable them to hit at least 20 million doses,” Jeff Zients, COVID-19 response coordinator for President Joe Biden, said.
While Pfizer/BioNTech and Moderna vaccines require two shots for full efficacy while Johnson & Johnson's requires one.